65464-10-0 Usage
Piperazine family
1-Propylpiperazin-2-one is a member of the piperazine family It belongs to a group of chemical compounds that share a common structure and properties.
Synthesis of pharmaceutical compounds
Commonly used in the synthesis of pharmaceutical compounds This chemical is frequently used as a building block or intermediate in the creation of various medications.
Cyclic urea derivative
1-Propylpiperazin-2-one is a cyclic urea derivative It has a ring structure in its molecular formula, which includes urea groups (a chemical structure composed of carbonyl groups and amide groups).
Biological activities
Antifungal, antibacterial, and antitumor properties The compound has been found to exhibit a range of biological activities, which may be useful in the development of new medications.
Precursor in medication production
Used as a precursor in the production of various medications 1-Propylpiperazin-2-one serves as a starting material or intermediate in the synthesis of different pharmaceutical compounds.
Therapeutic applications
Studied for its potential therapeutic applications Researchers are investigating the possible uses of this chemical in treating various diseases and conditions.
Building block in medicinal chemistry
Used as a building block for the synthesis of various organic compounds in medicinal chemistry and drug discovery 1-Propylpiperazin-2-one is an important component in the development of new drugs and the study of their potential effects.
Check Digit Verification of cas no
The CAS Registry Mumber 65464-10-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,4,6 and 4 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 65464-10:
(7*6)+(6*5)+(5*4)+(4*6)+(3*4)+(2*1)+(1*0)=130
130 % 10 = 0
So 65464-10-0 is a valid CAS Registry Number.
65464-10-0Relevant academic research and scientific papers
Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancers
Martini, Elisabetta,Ghelardini, Carla,Dei, Silvia,Guandalini, Luca,Manetti, Dina,Melchiorre, Michele,Norcini, Monica,Scapecchi, Serena,Teodori, Elisabetta,Romanelli, Maria Novella
, p. 1431 - 1443 (2008/09/18)
A series of 2-oxopiperazine, 4-aminomethyl-, 3-amino- and 3-aminomethylpiperidine analogues of DM235 (sunifiram) and MN19 (sapunifiram), two previously reported potent cognition-enhancers, have been synthesized and tested in the mouse passive-avoidance test. The compounds display minimal effective doses in the range 0.3-10 mg/kg. Although the new substances do not show improved activity when compared to the parent compounds, some useful information has been obtained to understand structure-activity relationships. In addition, the 3-aminopiperidine moiety appears to be a promising scaffold to synthesize new drugs endowed with cognition-enhancing activity.
